http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104382890-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104382890-B |
| titleOfInvention | The application in local nerve blocking medicine of the monoacetylaniline cationoid compound |
| abstract | The application in preparing local nerve blocking medicine of the N antifebrin cationoid compound.This cationic compound is a kind of quarternary ammonium salt compound, and structure is as shown in (I), and the X in formula is halogen atom.This compound is used alone, the feature such as can have that security is good and nerve block effect is strong, it is possible to plays reversible and lasting local anaesthesia effect in vivo, can use as long-acting and/or that realize selectively blocking local anesthetic or analgesic.The composition being particularly made up of with other local anesthetic this compound, when carrying out nerve block, more can have that rapid-action, effect is strong, long action time, to outstanding features such as neurotrosis are little. |
| priorityDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.